IMA vs MAR · rev $9.2M vs P/E 32, rev $26.19B
ImageneBio, Inc. (IMA) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
IMA currently screens at market cap $64.7M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the IMA and MAR stock pages for the full models.
Not investment advice.